Post-Trade Analysis: Vaxcyte Inc (PCVX) Slides -6.42, Closing at 105.56

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $112.80 in the prior trading day, Vaxcyte Inc (NASDAQ: PCVX) closed at $105.56, down -6.42%. In other words, the price has decreased by -$6.42 from its previous closing price. On the day, 1.78 million shares were traded. PCVX stock price reached its highest trading level at $112.91 during the session, while it also had its lowest trading level at $102.84.

Ratios:

Our goal is to gain a better understanding of PCVX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.

Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 18 ’24 when GUGGENHIME ANDREW sold 42,000 shares for $115.39 per share. The transaction valued at 4,846,508 led to the insider holds 90,383 shares of the business.

GUGGENHIME ANDREW bought 42,000 shares of PCVX for $4,866,960 on Oct 18 ’24. On Oct 07 ’24, another insider, PICKERING GRANT, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 7,098 shares for $109.21 each. As a result, the insider received 775,154 and left with 138,581 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 13962737664 and an Enterprise Value of 10354401280.

Stock Price History:

Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $46.16. The 50-Day Moving Average of the stock is -1.58%, while the 200-Day Moving Average is calculated to be 31.14%.

Shares Statistics:

The stock has traded on average 916.67K shares per day over the past 3-months and 683540 shares per day over the last 10 days, according to various share statistics. A total of 121.80M shares are outstanding, with a floating share count of 117.31M. Insiders hold about 3.69% of the company’s shares, while institutions hold 97.96% stake in the company. Shares short for PCVX as of 1728950400 were 9344117 with a Short Ratio of 10.19, compared to 1726185600 on 9705810. Therefore, it implies a Short% of Shares Outstanding of 9344117 and a Short% of Float of 8.58.

Most Popular